XSAT:DANCAN (Denmark)
Â
Unit (5 Ordinary shares & 2 Wrts)
kr
0.06
(-9.54%)
Apr 25
Business Description
DanCann Pharma AS
ISIN : DK0061410487
Share Class Description:
XSAT:DANCAN: Unit (5 Ordinary shares & 2 Wrts)Compare
Compare
Traded in other countries / regions
DANCAN.SwedenDAN.GermanyDCPXF.USA IPO Date
2020-11-12Description
DanCann Pharma AS is a Danish biopharmaceutical Company powered by cannabinoids. DanCann Pharma is a licensed production and distribution Company. The company is focused on discovering, developing, manufacturing, and commercializing novel cannabinoid therapeutics for a broad range of diseases.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.85 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 0.11 | |||||
| Beneish M-Score | 4.96 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -97.4 | |||||
| 3-Year EPS without NRI Growth Rate | -127.4 | |||||
| 3-Year FCF Growth Rate | -79.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 73.77 | |||||
| 9-Day RSI | 65.35 | |||||
| 14-Day RSI | 59.61 | |||||
| 6-1 Month Momentum % | 13.69 | |||||
| 12-1 Month Momentum % | -86.76 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.69 | |||||
| Quick Ratio | 0.69 | |||||
| Cash Ratio | 0.13 | |||||
| Days Inventory | 5.67 | |||||
| Days Sales Outstanding | 69.87 | |||||
| Days Payable | 57.02 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -40 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -49.94 | |||||
| Operating Margin % | -217.11 | |||||
| Net Margin % | -222.32 | |||||
| FCF Margin % | -375.44 | |||||
| ROE % | -25.53 | |||||
| ROA % | -21.45 | |||||
| ROIC % | -19.02 | |||||
| ROC (Joel Greenblatt) % | -153.01 | |||||
| ROCE % | -24.07 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.49 | |||||
| PB Ratio | 0.08 | |||||
| Price-to-Tangible-Book | 0.84 | |||||
| EV-to-EBIT | -0.6 | |||||
| EV-to-EBITDA | -0.7 | |||||
| EV-to-Revenue | 1.26 | |||||
| EV-to-FCF | -0.14 | |||||
| Earnings Yield (Greenblatt) % | -165.66 | |||||
| FCF Yield % | -255.59 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
DanCann Pharma AS Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 6.67 | ||
| EPS (TTM) (kr) | -0.215 | ||
| Beta | 0 | ||
| Volatility % | 171.24 | ||
| 14-Day RSI | 59.61 | ||
| 14-Day ATR (kr) | 0.014551 | ||
| 20-Day SMA (kr) | 0.04056 | ||
| 12-1 Month Momentum % | -86.76 | ||
| 52-Week Range (kr) | 0.01 - 0.592 | ||
| Shares Outstanding (Mil) | 166.63 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
DanCann Pharma AS Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
DanCann Pharma AS Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
DanCann Pharma AS Frequently Asked Questions
What is DanCann Pharma AS(XSAT:DANCAN)'s stock price today?
The current price of XSAT:DANCAN is kr0.06. The 52 week high of XSAT:DANCAN is kr0.59 and 52 week low is kr0.01.
When is next earnings date of DanCann Pharma AS(XSAT:DANCAN)?
The next earnings date of DanCann Pharma AS(XSAT:DANCAN) is 2024-05-31.
Does DanCann Pharma AS(XSAT:DANCAN) pay dividends? If so, how much?
DanCann Pharma AS(XSAT:DANCAN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers